| Danny Boyd Mccaughan, MD | |
|
5 River Bend Place, Suite C, Flowood, MS 39232 | |
| (601) 957-7345 | |
| (769) 251-5429 |
| Full Name | Danny Boyd Mccaughan |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Neonatal-perinatal Medicine |
| Location | 5 River Bend Place, Flowood, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730236605 | NPI | - | NPPES |
| 09854288 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080N0001X | Pediatrics - Neonatal-perinatal Medicine | 18314 (Mississippi) | Primary |
| Entity Name | Chattanooga Hamilton County Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154751931 PECOS PAC ID: 0547179731 Enrollment ID: O20040302001086 |
News Archive
In school-age children previously diagnosed with depression as preschoolers, a key brain region involved in emotion is smaller than in their peers who were not depressed, scientists have shown.
Johns Hopkins researchers have developed new guidelines - the first in more than 35 years - to govern the amount of blood ordered for surgical patients.
Three new publications by Inclusive Futures have revealed how people with disabilities were not only disproportionately and 'catastrophically' excluded from COVID-19 pandemic planning and relief efforts, but that representative disability groups were vital in aiding those left behind by the systems that are supposed to support them.
NPS Pharmaceuticals, Inc., a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the European Commission has granted orphan drug designation to Natpara (recombinant human parathyroid hormone (rhPTH[1-84]) for the treatment of hypoparathyroidism.
› Verified 6 days ago
| Entity Name | Erlanger Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477256303 PECOS PAC ID: 1153780226 Enrollment ID: O20230707000849 |
News Archive
In school-age children previously diagnosed with depression as preschoolers, a key brain region involved in emotion is smaller than in their peers who were not depressed, scientists have shown.
Johns Hopkins researchers have developed new guidelines - the first in more than 35 years - to govern the amount of blood ordered for surgical patients.
Three new publications by Inclusive Futures have revealed how people with disabilities were not only disproportionately and 'catastrophically' excluded from COVID-19 pandemic planning and relief efforts, but that representative disability groups were vital in aiding those left behind by the systems that are supposed to support them.
NPS Pharmaceuticals, Inc., a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the European Commission has granted orphan drug designation to Natpara (recombinant human parathyroid hormone (rhPTH[1-84]) for the treatment of hypoparathyroidism.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Danny Boyd Mccaughan, MD P O Box 320039, Flowood, MS 39232 Ph: (601) 957-7345 | Danny Boyd Mccaughan, MD 5 River Bend Place, Suite C, Flowood, MS 39232 Ph: (601) 957-7345 |
News Archive
In school-age children previously diagnosed with depression as preschoolers, a key brain region involved in emotion is smaller than in their peers who were not depressed, scientists have shown.
Johns Hopkins researchers have developed new guidelines - the first in more than 35 years - to govern the amount of blood ordered for surgical patients.
Three new publications by Inclusive Futures have revealed how people with disabilities were not only disproportionately and 'catastrophically' excluded from COVID-19 pandemic planning and relief efforts, but that representative disability groups were vital in aiding those left behind by the systems that are supposed to support them.
NPS Pharmaceuticals, Inc., a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the European Commission has granted orphan drug designation to Natpara (recombinant human parathyroid hormone (rhPTH[1-84]) for the treatment of hypoparathyroidism.
› Verified 6 days ago
Dr. Samuel A. Smith, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2946 Layfair Drive, Flowood, MS 39232 Phone: 601-420-8233 Fax: 601-936-5370 | |
David M Temple, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5 River Bend Place, Suite C, Flowood, MS 39232 Phone: 601-957-7345 Fax: 769-251-5429 | |
David F Wender, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5 River Bend Place, Suite C, Flowood, MS 39232 Phone: 601-975-7345 Fax: 769-251-5429 | |
Dr. Alisha Stockton Vaughn, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 151 E Metro Dr, Suite 102, Flowood, MS 39232 Phone: 601-992-2292 | |
Dr. Megan Lynn Washington, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 1020 River Oaks Dr, Ste 100, Flowood, MS 39232 Phone: 601-326-8700 Fax: 601-936-2252 | |
Carold Jason Miller, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5 River Bend Place, Suite C, Flowood, MS 39232 Phone: 601-957-7345 Fax: 769-251-5429 | |
Dr. Laura A. Barron, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2946 Layfair Drive, Flowood, MS 39232 Phone: 601-420-8233 Fax: 601-936-5370 |